Structural-functional analysis of drug targets for aspartate semialdehyde dehydrogenase.
ASADH
active site
amino acid biosynthesis
drug target
microbial inhibitors
Journal
Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
20
09
2023
revised:
17
01
2024
accepted:
25
01
2024
medline:
2
2
2024
pubmed:
2
2
2024
entrez:
1
2
2024
Statut:
aheadofprint
Résumé
Aspartate β-semialdehyde dehydrogenase (ASADH) is a key enzyme in the biosynthesis of essential amino acids in microorganisms and some plants. Inhibition of ASADHs can be a potential drug target for developing novel antimicrobial and herbicidal compounds. This review covers up-to-date information about sequence diversity, ligand/inhibitor-bound 3D structures, potential inhibitors, and key pharmacophoric features of ASADH useful in designing novel and target-specific inhibitors of ASADH. Most reported ASADH inhibitors have two highly electronegative functional groups that interact with two key arginyl residues present in the active site of ASADHs. The structural information, active site binding modes, and key interactions between the enzyme and inhibitors serve as the basis for designing new and potent inhibitors against the ASADH family.
Identifiants
pubmed: 38301800
pii: S1359-6446(24)00033-3
doi: 10.1016/j.drudis.2024.103908
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103908Informations de copyright
Copyright © 2024 Elsevier Ltd. All rights reserved.